Breadcrumb

CIM News

A new hope for men with metastatic prostate cancer

MUHC patients are the first enrolled in a new global Phase 1 clinical trial testing Actinium-225, a therapeutic agent used in nuclear precision medicine

An opportunity to learn, celebrate and connect during Black History Month at the RI-MUHC

An expert panel explored Equity, Diversity and Inclusion in research and healthcare

Building an inclusive clinical trial community

An innovative new unit at the RI-MUHC supports health researchers in launching and conducting impactful clinical trials

National Canadian Consortium of Clinical Trial Training (CANTRAIN) takes off successfully

Eighty-four graduate students from across Canada will share over $2 million in studentship and fellowship...

Raquel Zegarra del Carpio-O’Donovan appointed to the Order of Canada

The esteemed neuroradiologist was recognized by Governor General Mary Simon for her mentorship...

Sapha Barkati and Marina Klein receive the 2023 FMSQ prize for best research paper

Their highly cited publication in the New England Journal of Medicine describes the unique clinical presentation of mpox

Triple-negative breast cancer: a new clinical study opens new and promising therapeutic prospects

The RI-MUHC will host a new Phase 3 randomized clinical trial called TROPION-Breast04, as announced today...

The 2023 RI-MUHC Annual Report is online!

An invitation from Dr. Rhian Touyz

Code Life Research Awards Ceremony

Researchers at the RI-MUHC receive support from the Montreal General Hospital Foundation and the Cedars Cancer Foundation

RI-MUHC laboratory wins the International Freezer Challenge at McGill University

This impressive win for the Specimen Processing Laboratory at the Centre for Innovative Medicine is part of a push for greater...

Explore news and events at the RI-MUHC